Recruiting NA No Disease

New treatment option for No Disease

Official title Kaempferol Absorption and Pharmacokinetics Evaluation

ClinicalTrials.gov ID: NCT07322406

What this study is testing

What it's testing
This study is a multi-site clinical trial designed to evaluate how the body absorbs and processes Kaempferol, a naturally occurring compound found in many plant-based foods. The primary purpose of the study is to measure the pharmacokinetics and biological absorption of Kaempferol in healthy adults.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 70. Healthy volunteers may be eligible.

You may be able to join if

  • Adults aged 18 to 70 years
  • Healthy volunteers as determined by medical history and screening assessment
  • Ability to understand the study procedures and provide informed consent
  • Willingness and ability to comply with all study procedures, including dietary restrictions, clinic visits, blood draws, urine collection, and...
  • Willingness to abstain from restricted foods, beverages, and supplements as specified in the study protocol during the study period

You likely can't join if

  • Known allergy or hypersensitivity to Kaempferol or related flavonoids
  • Pregnancy or breastfeeding
  • Presence of significant acute or chronic medical conditions that could increase risk or interfere with study outcomes, including but not limited to:
  • Active or chronic infections
  • Cancer
  • Cardiovascular disease
See the full eligibility criteria
Who can join
  • Adults aged 18 to 70 years
  • Healthy volunteers as determined by medical history and screening assessment
  • Ability to understand the study procedures and provide informed consent
  • Willingness and ability to comply with all study procedures, including dietary restrictions, clinic visits, blood draws, urine collection, and follow-up assessments
  • Willingness to abstain from restricted foods, beverages, and supplements as specified in the study protocol during the study period
What rules you out
  • Known allergy or hypersensitivity to Kaempferol or related flavonoids
  • Pregnancy or breastfeeding
  • Presence of significant acute or chronic medical conditions that could increase risk or interfere with study outcomes, including but not limited to:
  • Active or chronic infections
  • Cancer
  • Cardiovascular disease
  • Neurological or neurodegenerative disorders
  • Metabolic or systemic inflammatory conditions
  • Use of prescription medications or supplements known to interfere with Kaempferol metabolism or pharmacokinetic assessment
  • Blood donation within 8 weeks prior to study enrollment
  • Participation in another treatment clinical study within a timeframe that could interfere with study results or participant safety
  • Any condition or circumstance that, in the judgment of the study investigator, would make participation unsafe or compromise data integrity

The study team makes the final eligibility decision.

Where it's taking place

  • New York, New York, United States
  • Chapel Hill, North Carolina, United States
  • Pittsburgh, Pennsylvania, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include New York, New York, United States; Chapel Hill, North Carolina, United States; Pittsburgh, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.